Anthropic’s push toward an October Nasdaq IPO at around $2 trillion valuation anchors trader sentiment, fueled by explosive revenue growth to an $65 billion annualized run rate by July and expectations of a second consecutive profitable quarter. The company’s Claude large language models continue gaining enterprise traction through superior coding performance and safety features, outpacing OpenAI in recent revenue benchmarks while securing major compute partnerships with Nvidia and Amazon. CEO Dario Amodei’s calls for industry-wide AI safety standards and slower frontier development introduce uncertainty, balancing bullish financial momentum against regulatory scrutiny and potential delays. With market-implied odds split closely between the $1.75–2.00T and $2.00–2.25T brackets, upcoming investor feedback sessions and the public S-1 filing will likely determine whether rapid scaling or safety concerns tilt the final valuation range.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено$1.75–$2.00T 44%
$2.00–$2.25T 32.9%
$1.50–$1.75T 19.6%
$1.25–$1.50T 2.5%
$55,871 Обс.
$55,871 Обс.
<$1.25T
1%
$1.25–$1.50T
3%
$1.50–$1.75T
20%
$1.75–$2.00T
44%
$2.00–$2.25T
33%
$2.25–$2.50T
2%
$2.50T+
1%
No IPO by December 31, 2027
1%
$1.75–$2.00T 44%
$2.00–$2.25T 32.9%
$1.50–$1.75T 19.6%
$1.25–$1.50T 2.5%
$55,871 Обс.
$55,871 Обс.
<$1.25T
1%
$1.25–$1.50T
3%
$1.50–$1.75T
20%
$1.75–$2.00T
44%
$2.00–$2.25T
33%
$2.25–$2.50T
2%
$2.50T+
1%
No IPO by December 31, 2027
1%
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Ринок відкрито: Aug 19, 2026, 9:45 AM ET
Вирішувач
0x69c47De9D...The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Вирішувач
0x69c47De9D...Anthropic’s push toward an October Nasdaq IPO at around $2 trillion valuation anchors trader sentiment, fueled by explosive revenue growth to an $65 billion annualized run rate by July and expectations of a second consecutive profitable quarter. The company’s Claude large language models continue gaining enterprise traction through superior coding performance and safety features, outpacing OpenAI in recent revenue benchmarks while securing major compute partnerships with Nvidia and Amazon. CEO Dario Amodei’s calls for industry-wide AI safety standards and slower frontier development introduce uncertainty, balancing bullish financial momentum against regulatory scrutiny and potential delays. With market-implied odds split closely between the $1.75–2.00T and $2.00–2.25T brackets, upcoming investor feedback sessions and the public S-1 filing will likely determine whether rapid scaling or safety concerns tilt the final valuation range.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання